Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model

R&D investment is the source of technological innovation of pharmaceutical enterprises, but it will be restricted by the funding level, especially in the context of major public health emergencies occurring more frequently, therefore exploring the impact of monetary policy uncertainty on the R&a...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jingyuan Yang, Ling Wang, Ziyuan Sun, Fangming Zhu, Yihui Guo, Yan Shen
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/4294aa07f8f84c2c8062f9cd7c8a8bcb
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4294aa07f8f84c2c8062f9cd7c8a8bcb
record_format dspace
spelling oai:doaj.org-article:4294aa07f8f84c2c8062f9cd7c8a8bcb2021-11-11T16:40:22ZImpact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model10.3390/ijerph1821115601660-46011661-7827https://doaj.org/article/4294aa07f8f84c2c8062f9cd7c8a8bcb2021-11-01T00:00:00Zhttps://www.mdpi.com/1660-4601/18/21/11560https://doaj.org/toc/1661-7827https://doaj.org/toc/1660-4601R&D investment is the source of technological innovation of pharmaceutical enterprises, but it will be restricted by the funding level, especially in the context of major public health emergencies occurring more frequently, therefore exploring the impact of monetary policy uncertainty on the R&D investment smoothing behavior of pharmaceutical manufacturing enterprises has important theoretical and practical value. Based on the relevant data of Chinese pharmaceutical manufacturing enterprises from 2012 to 2018, this paper studies the impact of monetary policy uncertainty on R&D investment smoothing behavior of pharmaceutical enterprises, and investigates whether there is a threshold effect. First, our results demonstrate that the empirical test results of this article support the hypothesis of R&D investment smoothing behavior of pharmaceutical manufacturing enterprises. Second, there is a negative correlation between monetary policy uncertainty and R&D investment smoothing behavior, and the shorter the period is, the higher the financing constraints of pharmaceutical enterprises are, and the more obvious the negative correlation is. Third, financing constraints have a single threshold effect on the R&D investment smoothing behavior of pharmaceutical manufacturing enterprises, with a threshold of −13.7693. Moreover, this conclusion can better promote the virtuous circle of the real economy of financial and pharmaceutical manufacturing enterprises. It is recommended that pharmaceutical manufacturing enterprises establish and improve the enterprise R&D reserve system, reduce the risk of R&D investment, play the role of R&D smoothing, and realize the sustainable development of enterprise R&D.Jingyuan YangLing WangZiyuan SunFangming ZhuYihui GuoYan ShenMDPI AGarticleR&D investment smoothing behaviorfinancing constraintsmonetary policy uncertaintypharmaceutical manufacturing enterprisesthreshold regression modelMedicineRENInternational Journal of Environmental Research and Public Health, Vol 18, Iss 11560, p 11560 (2021)
institution DOAJ
collection DOAJ
language EN
topic R&D investment smoothing behavior
financing constraints
monetary policy uncertainty
pharmaceutical manufacturing enterprises
threshold regression model
Medicine
R
spellingShingle R&D investment smoothing behavior
financing constraints
monetary policy uncertainty
pharmaceutical manufacturing enterprises
threshold regression model
Medicine
R
Jingyuan Yang
Ling Wang
Ziyuan Sun
Fangming Zhu
Yihui Guo
Yan Shen
Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model
description R&D investment is the source of technological innovation of pharmaceutical enterprises, but it will be restricted by the funding level, especially in the context of major public health emergencies occurring more frequently, therefore exploring the impact of monetary policy uncertainty on the R&D investment smoothing behavior of pharmaceutical manufacturing enterprises has important theoretical and practical value. Based on the relevant data of Chinese pharmaceutical manufacturing enterprises from 2012 to 2018, this paper studies the impact of monetary policy uncertainty on R&D investment smoothing behavior of pharmaceutical enterprises, and investigates whether there is a threshold effect. First, our results demonstrate that the empirical test results of this article support the hypothesis of R&D investment smoothing behavior of pharmaceutical manufacturing enterprises. Second, there is a negative correlation between monetary policy uncertainty and R&D investment smoothing behavior, and the shorter the period is, the higher the financing constraints of pharmaceutical enterprises are, and the more obvious the negative correlation is. Third, financing constraints have a single threshold effect on the R&D investment smoothing behavior of pharmaceutical manufacturing enterprises, with a threshold of −13.7693. Moreover, this conclusion can better promote the virtuous circle of the real economy of financial and pharmaceutical manufacturing enterprises. It is recommended that pharmaceutical manufacturing enterprises establish and improve the enterprise R&D reserve system, reduce the risk of R&D investment, play the role of R&D smoothing, and realize the sustainable development of enterprise R&D.
format article
author Jingyuan Yang
Ling Wang
Ziyuan Sun
Fangming Zhu
Yihui Guo
Yan Shen
author_facet Jingyuan Yang
Ling Wang
Ziyuan Sun
Fangming Zhu
Yihui Guo
Yan Shen
author_sort Jingyuan Yang
title Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model
title_short Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model
title_full Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model
title_fullStr Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model
title_full_unstemmed Impact of Monetary Policy Uncertainty on R&D Investment Smoothing Behavior of Pharmaceutical Manufacturing Enterprises: Empirical Research Based on a Threshold Regression Model
title_sort impact of monetary policy uncertainty on r&d investment smoothing behavior of pharmaceutical manufacturing enterprises: empirical research based on a threshold regression model
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/4294aa07f8f84c2c8062f9cd7c8a8bcb
work_keys_str_mv AT jingyuanyang impactofmonetarypolicyuncertaintyonrdinvestmentsmoothingbehaviorofpharmaceuticalmanufacturingenterprisesempiricalresearchbasedonathresholdregressionmodel
AT lingwang impactofmonetarypolicyuncertaintyonrdinvestmentsmoothingbehaviorofpharmaceuticalmanufacturingenterprisesempiricalresearchbasedonathresholdregressionmodel
AT ziyuansun impactofmonetarypolicyuncertaintyonrdinvestmentsmoothingbehaviorofpharmaceuticalmanufacturingenterprisesempiricalresearchbasedonathresholdregressionmodel
AT fangmingzhu impactofmonetarypolicyuncertaintyonrdinvestmentsmoothingbehaviorofpharmaceuticalmanufacturingenterprisesempiricalresearchbasedonathresholdregressionmodel
AT yihuiguo impactofmonetarypolicyuncertaintyonrdinvestmentsmoothingbehaviorofpharmaceuticalmanufacturingenterprisesempiricalresearchbasedonathresholdregressionmodel
AT yanshen impactofmonetarypolicyuncertaintyonrdinvestmentsmoothingbehaviorofpharmaceuticalmanufacturingenterprisesempiricalresearchbasedonathresholdregressionmodel
_version_ 1718432293293391872